This article has been corrected to fix erroneous information regarding Qiagen. The firm's Q4 revenues increased 5 percent, not decreased 5 percent, as the previous version of the article stated. Also, Qiagen didn't sign a recent companion diagnostic alliance with Amgen.

NEW YORK (GenomeWeb News) – Illumina, Pacific Biosciences, and Myriad Genetics led a group of companies which saw their stocks increase more than 20 percent in January from December as the GenomeWeb Daily News Index rose nearly 7 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.